Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-15

Clinical Trial Update: Generate and Test the Reliability of a PD Model of OXT on Pupillary Hippus as a Measure of CNS Activity [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update investigating oxytocin's effect on pupillary hippus as a measure of CNS activity. The study targets chronic pain and knee osteoa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxytocin (Oxytocin)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Chronic Pain, Osteoarthritis, Knee | Phase 2 | Status: RECRUITING